Tatsuya Furuichi Selected Research

Torrance Type Platyspondylic Lethal Skeletal Dysplasia

12/2015	Endoplasmic reticulum stress-mediated apoptosis contributes to a skeletal dysplasia resembling platyspondylic lethal skeletal dysplasia, Torrance type, in a novel Col2a1 mutant mouse line.
6/2011	ENU-induced missense mutation in the C-propeptide coding region of Col2a1 creates a mouse model of platyspondylic lethal skeletal dysplasia, Torrance type.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatsuya Furuichi Research Topics

Disease

2	Torrance Type Platyspondylic Lethal Skeletal Dysplasia 12/2015 - 06/2011
2	Metabolic Bone Diseases (Osteopenia) 10/2009 - 11/2008
2	Osteoarthritis 11/2008 - 10/2007
1	Desbuquois syndrome 01/2020
1	Bone Resorption 01/2018
1	Pulmonary Atelectasis 04/2011
1	Osteoporosis 01/2011
1	Rheumatoid Arthritis 06/2010
1	Sclerosis 11/2008
1	Intervertebral Disc Displacement (Herniated Disc) 05/2008
1	Ankylosing Spondylitis 01/2008
1	Diastrophic dysplasia 01/2008
1	Osteolysis 07/2007
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2002
1	Cleidocranial Dysplasia (Cleidocranial Dysostosis) 12/2002
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2002
1	Secondary Hyperparathyroidism 01/2002

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 04/2011 - 12/2002
1	GlycosaminoglycansIBA 01/2020
1	zinc-binding protein (zinc binding protein)IBA 01/2018
1	ZincIBA 01/2018
1	Mutant Proteins (Protein, Mutant)IBA 12/2015
1	Collagen Type II (Type II Collagen)IBA 06/2011
1	Surface-Active Agents (Surfactants)IBA 04/2011
1	GlucocorticoidsIBA 01/2011
1	SteroidsIBA 01/2011
1	Interleukin-17 (Interleukin 17)IBA 06/2010
1	CC ChemokinesIBA 06/2010
1	Collagen Type I (Type I Collagen)IBA 10/2009
1	calcium phosphateIBA 11/2008
1	Matrix Metalloproteinases (MMPs)IBA 05/2008
1	Sulfate TransportersIBA 01/2008
1	Proteoglycans (Proteoglycan)IBA 01/2008
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2008
1	Factor V (Coagulation Factor V)IBA 10/2007
1	Core Binding Factor beta SubunitIBA 12/2002
1	Carrier Proteins (Binding Protein)IBA 12/2002
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2002
1	1,25-dihydroxyvitamin DIBA 01/2002

Therapy/Procedure

1	Ovariectomy (Oophorectomy) 07/2007